PDGF-BB inhibits SP1/Angptl7 mediated chondro-endothelial crosstalk via stress-sensitivity Piezo1 regulation in osteoarthritis
Frontiers in Pharmacology · 15.07.2026 · 17
DOI: 10.3389/fphar.2026.1853487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.07.2026. Verfasst von Zhengchao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Medicine, Wuhan Fourth Hospital, Wuhan, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Osteoarthritis (OA) involves cartilage degradation and subchondral bone alterations, yet the mechanisms of chondro-endothelial crosstalk remain unclear. Stress-sensitive Piezo1 and SP1/Angptl7 signaling may play key roles in this process. This research aimed to investigate whether Platelet-derived growth factor (PDGF)-BB regulates chondro-endothelial crosstalk via Piezo1-mediated SP1/Angptl7 inhibition.
Methods
Single- and multiple-cell-component organoids (chondrocytes SW1353 and endothelial HMEC-1) were constructed using high-throughput 3D culture. Organoids were treated with MIA to induce OA-like changes, followed by PDGF-BB with or without Yoda1 (Piezo1 activator) or Angptl7. In vivo , OA was induced in rats by intraarticular MIA injection, and PDGF-BB or sodium hyaluronate (SH)-PDGF was administered. Histology and immunofluorescence were used to assess F-actin formation, Piezo1 activation, SP1 phosphorylation, Angptl7 and VEGF/Notch/DLL4 expression.
Results
PDGF-BB inhibited F-actin formation and reduced Piezo1 activation in OA chondrocytes. It suppressed SP1 phosphorylation and Angptl7 expression, downregulating VEGF/Notch/DLL4 signaling and reducing endothelial invasion in organoids. These effects were partially reversed by Yoda1 and fully reversed by Angptl7. In vivo , PDGF-BB and SH-PDGF attenuated cartilage degeneration and reduced Piezo1 activation, SP1 phosphorylation, and Angptl7 expression.
Discussion
PDGF-BB alleviates OA by inhibiting SP1/Angptl7-mediated chondro-endothelial crosstalk, partially via stress-sensitive Piezo1 regulation through cytoskeletal remodeling. Multiple-cell-component organoids provide a valuable in vitro model for studying cartilage pathophysiology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Sports Medicine, Wuhan Fourth Hospital, Wuhan, China.
- Hubei Provincial Sports Medicine Center, Wuhan, China.
- Hubei Key Laboratory of Sports Injury and Precision Treatment, Wuhan Fourth Hospital, Wuhan, China.
- Hubei Provincial Clinical Research Center for Orthopaedics, Wuhan, China.
- Department of Anesthesiology, Wuhan Fourth Hospital, Wuhan, China.
- Zibo First Hospital, Zibo Prevention and Treatment Hospital for Occupation Diseases, Zibo, China.
Zitieren
APA
Wang, Z., Cheng, J., Li, H., Zhang, Q., Zhu, P., & Cai, Y. (2026). PDGF-BB inhibits SP1/Angptl7 mediated chondro-endothelial crosstalk via stress-sensitivity Piezo1 regulation in osteoarthritis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1853487
Vancouver
Wang Z, Cheng J, Li H, Zhang Q, Zhu P, Cai Y. PDGF-BB inhibits SP1/Angptl7 mediated chondro-endothelial crosstalk via stress-sensitivity Piezo1 regulation in osteoarthritis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1853487
BibTeX
@article{Wang2026,
author = {Wang, Zhengchao and Cheng, Jiangxia and Li, Hongmei and Zhang, Qingsong and Zhu, Pengfei and Cai, Yu},
title = {PDGF-BB inhibits SP1/Angptl7 mediated chondro-endothelial crosstalk via stress-sensitivity Piezo1 regulation in osteoarthritis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1853487}
}
EUVIMED